Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14622681rdf:typepubmed:Citationlld:pubmed
pubmed-article:14622681lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:14622681lifeskim:mentionsumls-concept:C0521329lld:lifeskim
pubmed-article:14622681lifeskim:mentionsumls-concept:C0033554lld:lifeskim
pubmed-article:14622681lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:14622681lifeskim:mentionsumls-concept:C0751214lld:lifeskim
pubmed-article:14622681lifeskim:mentionsumls-concept:C2936719lld:lifeskim
pubmed-article:14622681lifeskim:mentionsumls-concept:C0458247lld:lifeskim
pubmed-article:14622681lifeskim:mentionsumls-concept:C0086597lld:lifeskim
pubmed-article:14622681pubmed:issue7lld:pubmed
pubmed-article:14622681pubmed:dateCreated2003-11-19lld:pubmed
pubmed-article:14622681pubmed:abstractTextIntrathecal administration of prostaglandin E(2) (PGE(2)) produces mechanical hyperalgesia, thermal hyperalgesia, and touch-evoked allodynia in rats. Experiments were conducted to examine the effects of intrathecal administration of relatively selective PGE(2) receptor (EP receptor) agonists to establish which spinal EP receptors mediate these behavioral effects of spinally administered PGE(2). Administration of either sulprostone (EP(3) receptor agonist) or PGE(1) alcohol (EP(4) receptor agonist) produced marked mechanical and thermal hyperalgesia and touch-evoked allodynia. Neither 17-phenyl trinor PGE(2) (EP(1) receptor agonist) nor butaprost (EP(2) receptor agonist) produced any significant changes in behavioral response thresholds to mechanical or thermal stimuli. However, 17-phenyl trinor PGE(2) (EP(1) receptor agonist) did produce marked touch-evoked allodynia. These data suggest that in rats activation of spinal EP(3) and EP(4) receptors by PGE(2) is important for development of both mechanical and thermal hyperalgesia as well as for touch-evoked allodynia. PGE(2)-induced allodynia also appears to involve activation of spinal EP(1) receptors.lld:pubmed
pubmed-article:14622681pubmed:languageenglld:pubmed
pubmed-article:14622681pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14622681pubmed:citationSubsetIMlld:pubmed
pubmed-article:14622681pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14622681pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14622681pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14622681pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14622681pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14622681pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14622681pubmed:statusMEDLINElld:pubmed
pubmed-article:14622681pubmed:monthSeplld:pubmed
pubmed-article:14622681pubmed:issn1526-5900lld:pubmed
pubmed-article:14622681pubmed:authorpubmed-author:RandichAlanAlld:pubmed
pubmed-article:14622681pubmed:authorpubmed-author:TurnbachMered...lld:pubmed
pubmed-article:14622681pubmed:authorpubmed-author:MebaneHannahHlld:pubmed
pubmed-article:14622681pubmed:issnTypePrintlld:pubmed
pubmed-article:14622681pubmed:volume4lld:pubmed
pubmed-article:14622681pubmed:ownerNLMlld:pubmed
pubmed-article:14622681pubmed:authorsCompleteYlld:pubmed
pubmed-article:14622681pubmed:pagination392-9lld:pubmed
pubmed-article:14622681pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:14622681pubmed:meshHeadingpubmed-meshheading:14622681...lld:pubmed
pubmed-article:14622681pubmed:meshHeadingpubmed-meshheading:14622681...lld:pubmed
pubmed-article:14622681pubmed:meshHeadingpubmed-meshheading:14622681...lld:pubmed
pubmed-article:14622681pubmed:meshHeadingpubmed-meshheading:14622681...lld:pubmed
pubmed-article:14622681pubmed:meshHeadingpubmed-meshheading:14622681...lld:pubmed
pubmed-article:14622681pubmed:meshHeadingpubmed-meshheading:14622681...lld:pubmed
pubmed-article:14622681pubmed:meshHeadingpubmed-meshheading:14622681...lld:pubmed
pubmed-article:14622681pubmed:meshHeadingpubmed-meshheading:14622681...lld:pubmed
pubmed-article:14622681pubmed:meshHeadingpubmed-meshheading:14622681...lld:pubmed
pubmed-article:14622681pubmed:meshHeadingpubmed-meshheading:14622681...lld:pubmed
pubmed-article:14622681pubmed:meshHeadingpubmed-meshheading:14622681...lld:pubmed
pubmed-article:14622681pubmed:meshHeadingpubmed-meshheading:14622681...lld:pubmed
pubmed-article:14622681pubmed:meshHeadingpubmed-meshheading:14622681...lld:pubmed
pubmed-article:14622681pubmed:year2003lld:pubmed
pubmed-article:14622681pubmed:articleTitleSpinal EP receptors mediating prostaglandin E2-induced mechanical hyperalgesia, thermal hyperalgesia, and touch-evoked allodynia in rats.lld:pubmed
pubmed-article:14622681pubmed:affiliationDepartment of Psychology, University of Alabama at Birmingham, Birmingham, AL, USA.lld:pubmed
pubmed-article:14622681pubmed:publicationTypeJournal Articlelld:pubmed